Tag: RAISE study

Reversible thrombolytic could alleviate US “tribalism” around tPA and help redefine...

Following Basking Biosciences’ recent announcement that the first acute ischaemic stroke patients have received its novel thrombolytic therapy as part of the Phase 2...

Reteplase demonstrates superiority to alteplase in acute ischaemic stroke trial

Reteplase has demonstrated potential as an alternative to alteplase in patients requiring intravenous thrombolysis (IVT) to treat acute ischaemic stroke, as per the findings...

Basking Biosciences closes US$55 million financing to further reversible stroke thrombolytic

Basking Biosciences has announced the close of US$55 million in financing, which will be used to accelerate clinical development of its novel thrombolytic therapy...